Clinical Trial Update: MIP Versus PCNL for Kidney Stone Disease [NA]

View source ↗

Summary

A University of California, San Diego trial comparing MIP to PCNL for nephrolithiasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephrolithiasis

Snippet

Sponsor: University of California, San Diego | Conditions: Kidney Stone | NA | Status: COMPLETED